130 related articles for article (PubMed ID: 8677911)
1. A phase II study of cisplatin/ifosfamide in recurrent/metastatic undifferentiated nasopharyngeal carcinoma among young blacks in southern Africa.
Stein ME; Ruff P; Weaving A; Fried J; Bezwoda WR
Am J Clin Oncol; 1996 Aug; 19(4):386-8. PubMed ID: 8677911
[TBL] [Abstract][Full Text] [Related]
2. Cisplatin, ifosfamide, and prolonged oral etoposide in the treatment of patients with extensive small cell lung carcinoma.
Glisson B; Lee JS; Palmer J; Fossella F; Shin DM; Murphy WK; Perez-Soler R; Hong WK
Cancer; 1998 Jan; 82(2):301-8. PubMed ID: 9445186
[TBL] [Abstract][Full Text] [Related]
3. Ifosfamide and cisplatin as neoadjuvant chemotherapy for advanced cervical carcinoma.
Leone B; Vallejo C; Perez J; Cuevas MA; Machiavelli M; Lacava J; Focaccia G; Ferreyra R; Suttora G; Romero A; Castaldi J; Arroyo A; Rabinovich M
Am J Clin Oncol; 1996 Apr; 19(2):132-5. PubMed ID: 8610635
[TBL] [Abstract][Full Text] [Related]
4. Phase I evaluation of sequential doxorubicin gemcitabine then ifosfamide paclitaxel cisplatin for patients with unresectable or metastatic transitional-cell carcinoma of the urothelial tract.
Dodd PM; McCaffrey JA; Hilton S; Mazumdar M; Herr H; Kelly WK; Icasiano E; Boyle MG; Bajorin DF
J Clin Oncol; 2000 Feb; 18(4):840-6. PubMed ID: 10673526
[TBL] [Abstract][Full Text] [Related]
5. Ifosfamide and doxorubicin combination chemotherapy for recurrent nasopharyngeal carcinoma patients.
Dede DS; Aksoy S; Cengiz M; Gullu I; Altundag K
Asian Pac J Cancer Prev; 2012; 13(5):2225-8. PubMed ID: 22901198
[TBL] [Abstract][Full Text] [Related]
6. Salvage ifosfamide-doxorubicin chemotherapy in patients with recurrent nasopharyngeal carcinoma pretreated with Cisplatin-based chemotherapy.
Altundag K; Aksoy S; Gullu I; Altundag O; Ozyar E; Yalcin S; Cengiz M; Akyol F
Med Oncol; 2004; 21(3):211-5. PubMed ID: 15456947
[TBL] [Abstract][Full Text] [Related]
7. Ifosfamide/cisplatin-based chemotherapy in metastatic undifferentiated nasopharyngeal carcinoma.
Stein ME; Drumea K
Laryngoscope; 1997 Nov; 107(11 Pt 1):1559. PubMed ID: 9369408
[No Abstract] [Full Text] [Related]
8. Phase II trial combining mitomycin with 5-fluorouracil, epirubicin, and cisplatin in recurrent and metastatic undifferentiated carcinoma of nasopharyngeal type.
Hasbini A; Mahjoubi R; Fandi A; Chouaki N; Taamma A; Lianes P; Cortès-Funes H; Alonso S; Armand JP; Cvitkovic E; Raymond E
Ann Oncol; 1999 Apr; 10(4):421-5. PubMed ID: 10370784
[TBL] [Abstract][Full Text] [Related]
9. Elimination of dose limiting toxicities of cisplatin, 5-fluorouracil, and leucovorin using a weekly 24-hour infusion schedule for the treatment of patients with nasopharyngeal carcinoma.
Chi KH; Chan WK; Shu CH; Law CK; Chen SY; Yen SH; Chen KY
Cancer; 1995 Dec; 76(11):2186-92. PubMed ID: 8635020
[TBL] [Abstract][Full Text] [Related]
10. Phase I trial of dose-escalated paclitaxel and carboplatin in combination with ifosfamide and filgrastim: preliminary results.
Palackdharry CS
Semin Oncol; 1996 Jun; 23(3 Suppl 6):78-83. PubMed ID: 8677455
[TBL] [Abstract][Full Text] [Related]
11. Experience with bleomycin, ifosfamide, and cisplatin in primary and recurrent cervical cancer.
Buxton EJ
Semin Oncol; 1992 Apr; 19(2 Suppl 5):9-17; discussion 17-8. PubMed ID: 1384148
[TBL] [Abstract][Full Text] [Related]
12. Lomustine (chloroethylnitrosourea [CCNU]), ifosfamide, bleomycin, vincristine, and cisplatin (CIBO-P) is an effective regimen for patients with poor prognostic refractory or multiple disease recurrent aggressive non-Hodgkin lymphoma.
Musolino A; Perrone MA; Michiara M; Delnevo D; Franciosi V; Di Blasio B; Ceci G; Camisa R; Ardizzoni A; Cocconi G
Cancer; 2005 May; 103(10):2109-17. PubMed ID: 15803492
[TBL] [Abstract][Full Text] [Related]
13. Phase II study of cisplatin, ifosfamide with mesna, and etoposide (PIE) chemotherapy for advanced non-small cell lung cancer.
Shirinian M; Lee JS; Dhingra HH; Greenberg J; Hong WK
Semin Oncol; 1992 Feb; 19(1 Suppl 1):49-53. PubMed ID: 1329212
[TBL] [Abstract][Full Text] [Related]
14. Phase II trial of paclitaxel, ifosfamide, and cisplatin in patients with recurrent head and neck squamous cell carcinoma.
Shin DM; Glisson BS; Khuri FR; Ginsberg L; Papadimitrakopoulou V; Lee JJ; Lawhorn K; Gillenwater AM; Ang KK; Clayman GL; Callender DL; Hong WK; Lippman SM
J Clin Oncol; 1998 Apr; 16(4):1325-30. PubMed ID: 9552033
[TBL] [Abstract][Full Text] [Related]
15. Etoposide (VP-16), ifosfamide/mesna, and cisplatin chemotherapy for advanced and recurrent carcinoma of the cervix.
Kredentser DC
Gynecol Oncol; 1991 Nov; 43(2):145-8. PubMed ID: 1743556
[TBL] [Abstract][Full Text] [Related]
16. Mitomycin, ifosfamide and cisplatin in advanced non-small cell lung cancer.
Soh LT; Tan EH; Ang PT
Singapore Med J; 1998 Aug; 39(8):357-8. PubMed ID: 9844496
[TBL] [Abstract][Full Text] [Related]
17. Phase II evaluation of ifosfamide/mesna in metastatic prostate cancer. A Southwest Oncology Group study.
Williamson SK; Wolf MK; Eisenberger MA; O'Rourke MA; Brannon W; Crawford ED
Am J Clin Oncol; 1996 Aug; 19(4):368-70. PubMed ID: 8677906
[TBL] [Abstract][Full Text] [Related]
18. The role of ifosfamide and systemic therapy in the management of carcinoma of the cervix.
Thigpen T; Vance R; Khansur T; Malamud F
Semin Oncol; 1996 Jun; 23(3 Suppl 6):56-64. PubMed ID: 8677451
[TBL] [Abstract][Full Text] [Related]
19. Phase II trial of chemotherapy with 5-fluorouracil, bleomycin, epirubicin, and cisplatin for patients with locally advanced, metastatic, or recurrent undifferentiated carcinoma of the nasopharyngeal type.
Taamma A; Fandi A; Azli N; Wibault P; Chouaki N; Hasbini A; Couteau C; Armand JP; Cvitkovic E
Cancer; 1999 Oct; 86(7):1101-8. PubMed ID: 10506692
[TBL] [Abstract][Full Text] [Related]
20. [Efficacy and safety evaluation of gemcitabine combined with ifosfamide in patients with advanced nasopharyngeal carcinoma after failure of platinum-based chemotherapy].
Hu S; He X; Dong M; Jia B; Zhou S; Yang J; Yang S; Zhang C; Liu P; Qin Y; Gui L
Zhonghua Zhong Liu Za Zhi; 2015 Aug; 37(8):632-6. PubMed ID: 26714607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]